Global $21 Billion Wound Management Devices Market to 2026: Product Launches, Approvals, M&A, Winning Strategies
15 sept. 2020 00h48 HE
|
Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Global Wound Management Devices Market By Product, By Application, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026" report has...
Growing Incidence of Hard-to-Heal Wounds, and Increased Wound Care Costs Drive Global Debridement Products Market
14 sept. 2020 04h08 HE
|
Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Wound Debridement Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...
Rafarma – MTP Partnership to Open Specialized Spas Offering Cannabis Treatments in Thailand
27 janv. 2020 08h45 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Jan. 27, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Following on the recently-announced partnership between Rafarma Pharmaceuticals, Inc. and Thailand’s...
Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkin
05 déc. 2019 09h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
DRGT Announces Hungarian Regulatory Authority Approval and Subsequent Initiation of a Phase 2 Trial of DRGT-119 in Patients With Chronic Anal Fissure
15 juil. 2019 09h00 HE
|
Druggability Technologies Holdings Ltd
BUDAPEST, Hungary, July 15, 2019 (GLOBE NEWSWIRE) -- Druggability Technologies Holdings (DRGT) today announced the start of a phase 2 randomized, double-blind, placebo-controlled trial to evaluate...
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board
21 juin 2019 09h22 HE
|
Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Rapid Self-healing Gel Market to exceed US$310 Mn by 2025: Global Market Insights, Inc.
06 mai 2019 05h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, May 06, 2019 (GLOBE NEWSWIRE) -- The rapid self-healing gel market revenue is set to rise from USD 190 million in 2018 to around USD 310 million by 2025, according to a...
Rapid Self-healing Gel Market to exceed US$310 Mn by 2025: Global Market Insights, Inc.
06 mai 2019 05h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, May 06, 2019 (GLOBE NEWSWIRE) -- The rapid self-healing gel market revenue is set to rise from USD 190 million in 2018 to around USD 310 million by 2025, according to a...
Endonovo Therapeutics Provides Corporate Update
26 avr. 2019 08h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Soft Tissue Repair Market Growth to Augment at 5.6% CAGR to Register $25,635 million by 2025
07 mars 2019 06h45 HE
|
Big Market Research
Portland, OR, March 07, 2019 (GLOBE NEWSWIRE) -- According to this research study, the global Soft Tissue Repair Market was valued at $16,554 million in 2017, and is expected to reach $25,635...